| Disruption of the ESX‐5 system of Mycobacterium tuberculosis causes loss of PPE protein secretion, reduction of cell wall integrity and strong attenuation D Bottai, M Di Luca, L Majlessi, W Frigui, R Simeone, F Sayes, W Bitter, ... Molecular microbiology 83 (6), 1195-1209, 2012 | 239 | 2012 |
| Bacteriophage Sb-1 enhances antibiotic activity against biofilm, degrades exopolysaccharide matrix and targets persisters of Staphylococcus aureus T Tkhilaishvili, L Lombardi, AB Klatt, A Trampuz, M Di Luca International journal of antimicrobial agents 52 (6), 842-853, 2018 | 189 | 2018 |
| Evaluation of the inhibitory effects of human serum components on bactericidal activity of human beta defensin 3 G Maisetta, M Di Luca, S Esin, W Florio, FL Brancatisano, D Bottai, ... Peptides 29 (1), 1-6, 2008 | 177 | 2008 |
| BaAMPs: the database of biofilm-active antimicrobial peptides M Di Luca, G Maccari, G Maisetta, G Batoni Biofouling 31 (2), 193-199, 2015 | 170 | 2015 |
| A novel chimeric cell-penetrating peptide with membrane-disruptive properties for efficient endosomal escape F Salomone, F Cardarelli, M Di Luca, C Boccardi, R Nifosì, G Bardi, ... Journal of controlled release 163 (3), 293-303, 2012 | 168 | 2012 |
| Strong immunogenicity and cross-reactivity of Mycobacterium tuberculosis ESX-5 type VII secretion-encoded PE-PPE proteins predicts vaccine potential F Sayes, L Sun, M Di Luca, R Simeone, N Degaiffier, L Fiette, S Esin, ... Cell host & microbe 11 (4), 352-363, 2012 | 149 | 2012 |
| Generation of Persister Cells of Pseudomonas aeruginosa and Staphylococcus aureus by Chemical Treatment and Evaluation of Their Susceptibility to Membrane … L Grassi, M Di Luca, G Maisetta, AC Rinaldi, S Esin, A Trampuz, G Batoni Frontiers in microbiology 8, 1917, 2017 | 141 | 2017 |
| Treatment of microbial biofilms in the post-antibiotic era: prophylactic and therapeutic use of antimicrobial peptides and their design by bioinformatics tools M Di Luca, G Maccari, R Nifosì Pathogens and disease 70 (3), 257-270, 2014 | 139 | 2014 |
| Interaction of Mycobacterium tuberculosis Cell Wall Components with the Human Natural Killer Cell Receptors NKp44 and Toll‐Like Receptor 2 S Esin, C Counoupas, A Aulicino, FL Brancatisano, G Maisetta, D Bottai, ... Scandinavian journal of immunology 77 (6), 460-469, 2013 | 127 | 2013 |
| Antimicrobial peptides design by evolutionary multiobjective optimization G Maccari, M Di Luca, R Nifosí, F Cardarelli, G Signore, C Boccardi, ... PLoS computational biology 9 (9), e1003212, 2013 | 101 | 2013 |
| Comparative analysis of the bactericidal activities of amphibian peptide analogues against multidrug-resistant nosocomial bacterial strains ML Mangoni, G Maisetta, M Di Luca, LMH Gaddi, S Esin, W Florio, ... Antimicrobial agents and chemotherapy 52 (1), 85-91, 2008 | 95 | 2008 |
| Inhibitory effect of the human liver-derived antimicrobial peptide hepcidin 20 on biofilms of polysaccharide intercellular adhesin (PIA)-positive and PIA-negative strains of … FL Brancatisano, G Maisetta, M Di Luca, S Esin, D Bottai, R Bizzarri, ... Biofouling 30 (4), 435-446, 2014 | 92 | 2014 |
| Bio-orthogonal chemistry and reloadable biomaterial enable local activation of antibiotic prodrugs and enhance treatments against Staphylococcus aureus infections M Czuban, S Srinivasan, NA Yee, E Agustin, A Koliszak, E Miller, I Khan, ... ACS central science 4 (12), 1624-1632, 2018 | 90 | 2018 |
| TbD1 deletion as a driver of the evolutionary success of modern epidemic Mycobacterium tuberculosis lineages D Bottai, W Frigui, F Sayes, M Di Luca, D Spadoni, A Pawlik, M Zoppo, ... Nature communications 11 (1), 684, 2020 | 85 | 2020 |
| Synergistic Activity of Fosfomycin, Ciprofloxacin, and Gentamicin Against Escherichia coli and Pseudomonas aeruginosa Biofilms L Wang, M Di Luca, T Tkhilaishvili, A Trampuz, M Gonzalez Moreno Frontiers in microbiology 10, 2522, 2019 | 75 | 2019 |
| Characterization, Antibiofilm, and Depolymerizing Activity of Two Phages Active on Carbapenem-Resistant Acinetobacter baumannii G Vukotic, M Obradovic, K Novovic, M Di Luca, B Jovcic, D Fira, H Neve, ... Frontiers in medicine 7, 426, 2020 | 72 | 2020 |
| Antibacterial efficacy of two commercially available bacteriophage formulations, staphylococcal bacteriophage and PYO bacteriophage, against methicillin-resistant … T Tkhilaishvili, L Wang, A Tavanti, A Trampuz, M Di Luca Frontiers in microbiology 11, 110, 2020 | 70 | 2020 |
| Synergistic antibiotic activity against planktonic and biofilm-embedded Streptococcus agalactiae, Streptococcus pyogenes and Streptococcus oralis M Gonzalez Moreno, A Trampuz, M Di Luca Journal of antimicrobial Chemotherapy 72 (11), 3085-3092, 2017 | 65 | 2017 |
| In vitro anti-biofilm activity of a biphasic gentamicin-loaded calcium sulfate/hydroxyapatite bone graft substitute ME Butini, S Cabric, A Trampuz, M Di Luca Colloids and Surfaces B: Biointerfaces 161, 252-260, 2018 | 64 | 2018 |
| The ESX-5 Associated eccB5-eccC5 Locus Is Essential for Mycobacterium tuberculosis Viability M Di Luca, D Bottai, G Batoni, M Orgeur, A Aulicino, C Counoupas, ... PLoS One 7 (12), e52059, 2012 | 63 | 2012 |
